Company / Operating Margin
Bioventus Inc. Operating Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
9.5%
FY2025
5-year range
-32.7% / 9.5%
FY2021-FY2025
Trend
+458.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed +458% YoY in FY2025, a notable deviation from the 4-year average annual change of -21%.
Based on SEC 10-K filings.
9.5% in FY2025 with a 3-year CAGR of +42.2%.
Improved from 2.8% to 9.5% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +42.2pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 458.5% year-over-year.
- Lowest operating margin in the period was in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 9.5% | +458.5% |
| FY2024 | -2.6% | -194.6% |
| FY2023 | 2.8% | +108.6% |
| FY2022 | -32.7% | -456.2% |
| FY2021 | 9.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026